Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
amivantamab
×
Clear all
Filters
3
NCT06662786
2026-04-13
OrigAMI-2
Janssen Research & Development, LLC
Phase 3
Recruiting
1,000 enrolled
NCT06750094
2026-04-13
OrigAMI-3
Janssen Research & Development, LLC
Phase 3
Recruiting
700 enrolled